Diabetes Mellitus and Complications. Part 2

Flores Ramírez J; Aguilar Rebolledo F

2007, Number 1-2

<< Back Next >>

Plasticidad y Restauración Neurológica 2007; 6 (1-2)

Diabetes Mellitus and Complications. Part 2

Flores RJ, Aguilar RF

Full text

How to cite this article

Language: Spanish
References: 21
Page: 35-44
PDF size: 256.76 Kb.

ABSTRACT

The therapeutic interventions, like the metabolic control, the diet, the change of the life style and the physical exercise, reduce the risk of undergoing chronic complications. Nevertheless clinical conditions denominated risk exist factors that they require of a good control, such as the normalization of the arterial pressure, the lipids serum, the control of the glucose, the control of uric acid, the overweight and the obesity and the suspension of the alcohol consumption and the tobacco. On the other hand, the systematic exploration of the feet, to correct the structural abnormalities and to avoid the foot ulcers of inadequate weight, combined to the own peripheral nervous system upheavals of the diabetes, is factors of great importance for the prevention of the complications, remembering with clarity that all the therapeutic alternatives are important and to limit itself the metabolic control not solely.

REFERENCES

Aguilar-Rebolledo F, Rayo-Mares D. Neuropatía Diabética, Parte 2. Patología, procedimientos diagnósticos, prevención y tratamiento. Rev Med IMSS 2000;38:257-266.
De Craen AJM, Vickers AJ, Tijssen JGP, Kleijnen J. Number needed-to-treat and placebo-controlled trials. Lancet 1998;351:310.
Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. Br Med J 1996;313:735-938.
Ludbrook J. Multiple comparison procedures updated. Clín Exp Pharmacol Physiol 1998;25: 937-1032.
Hollis S. Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials Br Med J 1999;319:670-674.
Begg C, Cho M, Eastwood 5 et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-939.
Freemantle N, Mason JM, Haines A, Eccles MP. CDNSDRT: an important step toward evidence-based health care. Consolidated Standards of Reporting Trials. Ann lntern Med 1997;126:81-83.
Eggert M, Smith GD. Bias in location and selection of studies. Br Med J 1998;316: 61-66.
Deyo RA, Psaty BM, Simon GS et al. The messenger under attack-intimidation of researchers by special-interest groups. N Engl J Med 1997;336:1176-1180.
Eggert M, Smith GD, Schneider M, Minder C. Bias in metaanalysis detected by a simple. graphical test. Br Med J 1997;31:629-634.
Eggert M, Smith GD. Bias in location and selection of studies. Br Med J 1998;316: 61-66.
The Diabetes Control and Complications Trial Research Group. Tire effect of intensive treatment of diabetes on the development and Progression of long term complications insulin dependent diabetes mellitus. N EngI J Med 1993;329:977-986.
Buchanan TA, Catalano PM. The pathogenesis of GDM: Implications by diabetes after pregnancy. Diabetes Rey 1995;3:584-6O1.
Aguilar-Salinas CA, Gómez-Pérez FJ, Lerman-Garber I, Pérez-Méndez O, Posadas-Romero C. Diagnóstico y tratamiento de las dislipidemias: Posición de la Sociedad Mexicana de Nutrición y Endocrinología. Revista de Nutrición y Endocrinología 2004 (en prensa).
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 an projections for 2030. Diabetes Care 2004;27:1047-1053.
American Diabetes Association: Peripheral Arterial Disease in People with Diabetes (Consensus Statement). Diabetes Care 2003;26 (12):3333-3341.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes mellitus (Technical Review). Diabetes Care 2002;25:134-147.
American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 2004;27 (Supl 1):S72-S73.
American Diabetes Association: Smoking and diabetes (Position Statement). Diabetes Care 2004;27 (Supl 1):S74-S75.
Chibanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones SW, Materson BJ, Oprail S, Wright JT Jr, Roccella EJ. The National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; the National High blood Pressure Education Program Coordinating Committee: The Seventh Report of the Join National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.